Streetbeat News

Earnings

RHHBY

Roche's Genentech has announced new long-term data for Vabysmo, showing sustained improvements in retinal drying and vision for patients with Retinal Vein Occlusion (RVO). The data indicates that up to 60% of patients could extend treatment intervals to three or four months. Detailed results from two global Phase III RVO studies will be presented at the Angiogenesis, Exudation, and Degeneration 2024 conference. Vabysmo is approved in the U.S. for RVO and in over 90 countries for wet AMD and DME.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:33 am

TSLA

Tesla Inc's Chief Designer Franz von Holzhausen had an exchange with the Cybertruck account on X, featuring a black-wrapped Cybertruck photo from Tesla's Q4 earnings report. The Cybertruck's design is considered futuristic, and Tesla's Supply Chain VP Karn Budhiraj noted strong conversion of reservations to orders, with potential to sell out all builds in 2024. Elon Musk aims to deliver 250,000 Cybertrucks in North America.

Portfolio Pulse from Anan Ashraf

January 26, 2024 | 4:40 am

TSLA

Elon Musk clarified his previous comments about the Dojo supercomputer's success odds, comparing them to the initial low success expectations he had for Tesla and SpaceX. During Tesla's Q4 earnings call, Musk described Dojo as a 'long shot' with high risk and high potential payoff, noting that Tesla is scaling the project and planning future versions.

Portfolio Pulse from Anan Ashraf

January 26, 2024 | 3:29 am

ARKK

ARKW

TSLA

Tesla, Inc. (TSLA) shares dropped over 12% after Q4 earnings missed expectations, leading to a market cap loss of $80.4 billion. Despite this, Ark Invest, led by Cathie Wood, purchased $32.5 million worth of Tesla shares through ARKK and ARKW ETFs. Ark remains bullish on Tesla, with a $2000 price target by 2027, largely based on the potential of Tesla's robotaxi service. The short-term outlook for Tesla stock is uncertain, with potential influences including economic data releases and the Fed's rate decision.

Portfolio Pulse from Shanthi Rexaline

January 26, 2024 | 3:06 am

AMD

INTC

NVDA

PCSA

TSLA

U.S. stocks closed higher with Intel, Nvidia, AMD, Processa Pharmaceuticals, and Tesla being the focus of investors. Intel rose 0.94% after reporting a 10% year-over-year revenue increase. Nvidia fell 0.42% but remains a key player in AI. AMD gained 1.14% with raised estimates from UBS. Processa Pharmaceuticals surged 148.78% on successful drug trial results. Tesla dropped 12.13% after missing Q4 revenue and EPS estimates, with analysts expressing concern over its valuation.

Portfolio Pulse from Benzinga Neuro

January 26, 2024 | 2:14 am

INTC

Intel Corporation's Q1 2024 revenue guidance fell short by over $1 billion, surprising analysts. Wedbush's Matt Bryson noted the shortfall was due to excess inventory from Q4 overshipping, leading to a backlog. Despite this, Bryson expects a recovery towards the end of 2024. Intel's Q4 revenue was $15.4 billion, beating estimates, but Q1 guidance of $12.2-$13.2 billion is below the expected $14.2 billion. BofA's Vivek Arya predicted the miss, citing multiple headwinds. Intel is also a partner in the NAIRR pilot initiative.

Portfolio Pulse from Benzinga Neuro

January 26, 2024 | 2:07 am

LLY

TSLA

Tesla Inc. (TSLA) experienced a 12% drop in stock price after a Q4 revenue miss, causing its market cap to fall below that of Eli Lilly (LLY). Eli Lilly's market value increased due to the success of its weight-loss drugs, with shares up 59% for the year. Tesla's earnings report was criticized, and its growth forecasts are weak, while Eli Lilly receives bullish forecasts from analysts, including a potential 140% stock increase by 2028 as predicted by Goldman Sachs.

Portfolio Pulse from Benzinga Neuro

January 26, 2024 | 12:58 am

FFIC

Flushing Financial (NASDAQ:FFIC) reported Q4 adjusted earnings of $0.25 per share, surpassing the consensus estimate of $0.23, and sales of $53.49M, exceeding the $48.12M estimate. However, this represents a 56.14% decrease in earnings per share compared to last year, despite a 14.90% increase in sales over the same period.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 11:05 pm

CVLY

Codorus Valley Bancorp (NASDAQ:CVLY) reported Q4 sales of $23.41M, surpassing the analyst consensus estimate of $22.50M by 4.03%. However, this represents a 6.12% decrease from the $24.93M in sales reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 10:48 pm

AMZN

17-year-old Bella Lin has turned her side hustle, GuineaLoft, into a successful business on Amazon, generating $34K a month by selling improved living spaces for guinea pigs. Starting with $2,000 of her savings, Lin's business earned over $410,000 last year. She's considering delaying college to focus on her business, which she's expanding through reinvestment in marketing and R&D.

Portfolio Pulse from Adam Eckert

January 25, 2024 | 10:41 pm